Effectiveness of Prism Spectacles in Patients With Age Related Macular Degeneration
NCT ID: NCT05437302
Last Updated: 2022-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2021-10-04
2022-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Outcome and Effectiveness Between Micropulse Diode Laser Cyclophotocoagulation and Cyclocryoablation in Treatment of Refractory Glaucoma
NCT05437614
Study of Application of Pulse Electrical Stimulation Around Eye in Glaucoma Patients
NCT05159414
The Performances of Spectral Domain Optical Coherence Tomography (OCT) for Distinguishing Glaucomatous Eyes
NCT01067482
Prospective Evaluation of the Efficacy of Pascal Laser Iridotomy and Pascal Laser Peripheral Iridoplasty: A Pilot Study
NCT01020071
Efficacy and Tolerability of Preservative-free 0.0015% Tafluprost in Glaucoma Patients
NCT03104621
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
interventional
prism spectacles prescribed
prism spectacle
a prism is dispensed in prescription glasses
non interventional
presbyopia glasses prescribed
prism spectacle
a prism is dispensed in prescription glasses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prism spectacle
a prism is dispensed in prescription glasses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients of both genders (male and female).
* Participants who will be willing to give informed consent for participation in the study.
Exclusion Criteria
* Presence of disorders causing choroidal neovascularization other than age related macular degeneration.
* Patients with mental illness, dementia, and severe physical limitations
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Faisalabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
mehreen tanveer
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayesha Kiran
Role: STUDY_DIRECTOR
University of Faisalabad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mehreen
Rawalpindi, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ufaisalabad
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.